Total Payments
$4,476
2024 Payments
$200.00
Companies
22
Transactions
189
Medicare Patients
966
Medicare Billing
$123,559
Payment Breakdown by Category
Food & Beverage$4,224 (94.4%)
Consulting$200.00 (4.5%)
Education$52.50 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,224 | 186 | 94.4% |
| Consulting Fee | $200.00 | 1 | 4.5% |
| Education | $52.50 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $963.75 | 49 | $0 (2021) |
| Alkermes, Inc. | $652.24 | 20 | $0 (2023) |
| Allergan, Inc. | $509.48 | 34 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $407.48 | 14 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $270.28 | 5 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $200.00 | 1 | $0 (2024) |
| Lundbeck LLC | $180.82 | 10 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $163.54 | 4 | $0 (2018) |
| ITI, Inc. | $153.08 | 3 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $151.49 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $200.00 | 1 | Janssen Scientific Affairs, LLC ($200.00) |
| 2023 | $496.38 | 13 | IDORSIA PHARMACEUTICALS US INC ($151.49) |
| 2022 | $302.29 | 6 | ABBVIE INC. ($124.86) |
| 2021 | $507.26 | 15 | Alkermes, Inc. ($191.60) |
| 2020 | $154.42 | 5 | Otsuka America Pharmaceutical, Inc. ($110.42) |
| 2019 | $371.22 | 15 | Janssen Pharmaceuticals, Inc ($102.90) |
| 2018 | $1,273 | 78 | Sunovion Pharmaceuticals Inc. ($498.11) |
| 2017 | $1,172 | 56 | Alkermes, Inc. ($306.69) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | Janssen Scientific Affairs, LLC | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Neuroscience | ||||||
| 11/09/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Neuroscience | ||||||
| 11/08/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: CNS | ||||||
| 09/14/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CNS | ||||||
| 08/29/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: PSYCHOLOGY | ||||||
| 07/27/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: INSOMNIA | ||||||
| 05/17/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: CNS | ||||||
| 05/10/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: PSYCHOLOGY | ||||||
| 04/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: INSOMNIA | ||||||
| 04/20/2023 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $23.15 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $99.50 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/17/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: INSOMNIA | ||||||
| 02/08/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: CNS | ||||||
| 01/26/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: INSOMNIA | ||||||
| 09/07/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: PSYCHOLOGY | ||||||
| 08/31/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $11.94 | General |
| Category: PSYCHOLOGY | ||||||
| 08/03/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: PSYCHOLOGY | ||||||
| 05/11/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $117.65 | General |
| Category: PSYCHIATRY | ||||||
| 05/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.86 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2022 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2021 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $23.22 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: CNS | ||||||
| 12/10/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: CNS | ||||||
| 12/02/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $94.06 | General |
| Category: CNS | ||||||
| 10/28/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $100.58 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 168 | 362 | $82,767 | $24,019 |
| 2022 | 2 | 216 | 467 | $96,497 | $31,650 |
| 2021 | 3 | 246 | 544 | $107,936 | $38,864 |
| 2020 | 3 | 336 | 554 | $101,307 | $29,026 |
Total Patients
966
Total Services
1,927
Medicare Billing
$123,559
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 298 | $62,632 | $17,869 | 28.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 38 | $10,003 | $3,418 | 34.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 13 | $6,588 | $1,593 | 24.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 13 | $3,544 | $1,138 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 430 | $83,504 | $27,035 | 32.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 37 | 37 | $12,993 | $4,615 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 478 | $90,564 | $32,472 | 35.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 44 | 44 | $14,585 | $5,615 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 22 | $2,788 | $777.19 | 27.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 167 | 363 | $69,790 | $19,303 | 27.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 130 | 151 | $18,415 | $5,709 | 31.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 39 | 40 | $13,102 | $4,013 | 30.6% |
About Dr. Vahag Vartanian, M.D
Dr. Vahag Vartanian, M.D is a Psychiatry healthcare provider based in Racine, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578525580.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vahag Vartanian, M.D has received a total of $4,476 in payments from pharmaceutical and medical device companies, with $200.00 received in 2024. These payments were reported across 189 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,224).
As a Medicare-enrolled provider, Vartanian has provided services to 966 Medicare beneficiaries, totaling 1,927 services with total Medicare billing of $123,559. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Racine, WI
- Active Since 04/05/2006
- Last Updated 07/21/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1578525580
Products in Payments
- LATUDA (Drug) $963.75
- VRAYLAR (Drug) $583.72
- ABILIFY MAINTENA (Drug) $508.84
- Aristada 441 mg (Drug) $350.88
- SPRAVATO (Drug) $302.90
- ARISTADA (Drug) $185.43
- INVEGA SUSTENNA (Drug) $167.38
- Trintellix (Drug) $162.03
- CAPLYTA (Drug) $153.08
- QUVIVIQ (Drug) $151.49
- INGREZZA (Drug) $138.44
- Auvelity (Drug) $99.50
- LYBALVI (Drug) $94.06
- QELBREE (Drug) $80.09
- REXULTI (Drug) $79.46
- MYDAYIS (Drug) $50.93
- VYVANSE (Drug) $50.67
- NAMZARIC (Drug) $39.34
- VIIBRYD (Drug) $37.87
- Aptensio XR (Drug) $29.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.